نتایج جستجو برای: pertechnetate
تعداد نتایج: 857 فیلتر نتایج به سال:
Thyroid scintigraphy is a method that formed more than 60 years ago and retains its importance for the diagnosis assessment of risk nodular malignancy. The review examines use scintigraphic in functional metabolic goiter. Prerequisites thyroid nodes screening with short-lived 99mTc-pertechnetate are outlined. Information provided on principles preparation pharmacokinetics, as well variants acti...
We characterized the scintigraphic and sonographic appearance of the thyroid gland in clinically normal horses to establish the value of these modalities for assessment of the thyroid gland in this species. Horses were divided into two age groups. One group consisted of eight horses between 3 and 10 years of age and the other of seven horses between 11 and 20 years of age. Total T4 concentratio...
The effect of intracarotid nonionic contrast media on the blood-brain barrier in acute hypertension.
PURPOSE To determine whether acute hypertension (HT) is a risk factor for damage to the blood-brain barrier in carotid angiography with nonionic contrast media. METHODS Anesthetized rats received intravenous injections of technetium-99m-pertechnetate and horseradish peroxidase. Two groups of rats received metaraminol to raise their blood pressure to between 165 and 190 mmHg peak systolic and ...
OBJECTIVES In this study, we aimed to evaluate the efficacy of thyroid volume measurement using 99mTc pertechnetate single-photon emission computed tomography (SPECT) images, acquired by the standardized uptake value (SUV)-shape scheme designed by our expert team. METHODS A total of 18 consecutive patients with Graves' disease (GD) were subjected to both ultrasonographic and 99mTc pertechneta...
Extremely high doses of radioiodine required for treatment of Graves’ hyperthyroidism: a case report
INTRODUCTION Radioactive iodine ((131)I) is widely prescribed for treatment of Graves' disease. A dose of 370 to 555 MBq (10 to 15 mCi) is usually enough, but reports of improved remission rates with single doses up to 20-30 mCi, and 38.5 mCi at most, exist. CASE PRESENTATION A 53-year-old male patient was evaluated in September 2005, with symptoms of thyrotoxicosis for 2 years. He presented ...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید